Dr. George's precision prevention research examines the incidence and prevalence of hereditary breast and ovarian cancer syndrome in women from the Caribbean. Ovarian cancer, starts in the Fallopian tube epithelia (FTE), so she and her researchers use these FTE cells to study the biology of early genomic changes that lead to cancer including a detailed characterization of pro-tumorigenic metabolic and oxidizing insults.